CLINICAL_TRIALS
trial_result
· 2016-11-23
Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) [Phase 1]
Summary
This Phase 1 study reports on the safety, pharmacokinetics, and pharmacodynamics of Elbasvir (MK-8742) in male participants infected with hepatitis C.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis, Viral, Human | Phase 1 | Status: COMPLETED | Results posted: 2016-11-23